RGEN Covered Call Strategy
RGEN (Repligen Corporation), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands.
RGEN (Repligen Corporation) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $6.04B, a trailing P/E of 117.35, a beta of 1.09 versus the broader market, a 52-week range of 106.92-175.77, average daily share volume of 983K, a public-listing history dating back to 1986, approximately 2K full-time employees. These structural characteristics shape how RGEN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.09 places RGEN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 117.35 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a covered call on RGEN?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current RGEN snapshot
As of May 15, 2026, spot at $103.34, ATM IV 51.30%, IV rank 3.97%, expected move 14.71%. The covered call on RGEN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this covered call structure on RGEN specifically: RGEN IV at 51.30% is on the cheap side of its 1-year range, which means a premium-selling RGEN covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 14.71% (roughly $15.20 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RGEN expiries trade a higher absolute premium for lower per-day decay. Position sizing on RGEN should anchor to the underlying notional of $103.34 per share and to the trader's directional view on RGEN stock.
RGEN covered call setup
The RGEN covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RGEN near $103.34, the first option leg uses a $110.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RGEN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RGEN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $103.34 | long |
| Sell 1 | Call | $110.00 | $4.20 |
RGEN covered call risk and reward
- Net Premium / Debit
- -$9,914.00
- Max Profit (per contract)
- $1,086.00
- Max Loss (per contract)
- -$9,913.00
- Breakeven(s)
- $99.14
- Risk / Reward Ratio
- 0.110
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
RGEN covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on RGEN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$9,913.00 |
| $22.86 | -77.9% | -$7,628.21 |
| $45.71 | -55.8% | -$5,343.41 |
| $68.55 | -33.7% | -$3,058.62 |
| $91.40 | -11.6% | -$773.82 |
| $114.25 | +10.6% | +$1,086.00 |
| $137.10 | +32.7% | +$1,086.00 |
| $159.95 | +54.8% | +$1,086.00 |
| $182.79 | +76.9% | +$1,086.00 |
| $205.64 | +99.0% | +$1,086.00 |
When traders use covered call on RGEN
Covered calls on RGEN are an income strategy run on existing RGEN stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
RGEN thesis for this covered call
The market-implied 1-standard-deviation range for RGEN extends from approximately $88.14 on the downside to $118.54 on the upside. A RGEN covered call collects premium on an existing long RGEN position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether RGEN will breach that level within the expiration window. Current RGEN IV rank near 3.97% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on RGEN at 51.30%. As a Healthcare name, RGEN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RGEN-specific events.
RGEN covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RGEN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RGEN alongside the broader basket even when RGEN-specific fundamentals are unchanged. Short-premium structures like a covered call on RGEN carry tail risk when realized volatility exceeds the implied move; review historical RGEN earnings reactions and macro stress periods before sizing. Always rebuild the position from current RGEN chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on RGEN?
- A covered call on RGEN is the covered call strategy applied to RGEN (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With RGEN stock trading near $103.34, the strikes shown on this page are snapped to the nearest listed RGEN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are RGEN covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the RGEN covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 51.30%), the computed maximum profit is $1,086.00 per contract and the computed maximum loss is -$9,913.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a RGEN covered call?
- The breakeven for the RGEN covered call priced on this page is roughly $99.14 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RGEN market-implied 1-standard-deviation expected move is approximately 14.71%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on RGEN?
- Covered calls on RGEN are an income strategy run on existing RGEN stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current RGEN implied volatility affect this covered call?
- RGEN ATM IV is at 51.30% with IV rank near 3.97%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.